The Management of hypertension
著者
書誌事項
The Management of hypertension
(Handbook of hypertension / series editors: W. H. Birkenhäger and J. L. Reid, v. 13)
Elsevier, 1990
大学図書館所蔵 全8件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
The past three decades have witnessed a veritable explosion in knowledge of high blood pressure and related cardiovascular phenomena. It revolves around two research tracks, one involving new physiologic and pathophysiologic mechanisms, the other the development of increasingly specific drugs to block homeostatic or pathogenic pressor mechanisms at specific points. It has become clear that all hypertension is not alike. It can no longer be analyzed and treated as if it were a single pathologic or clinical syndrome. This means that those millions of people the world over who have in common high blood pressure do not all have the same disorder. In this context, hypertension is a biophysical sign, for which there can be many different causes. It follows that there are differences in drug responsiveness according to these various biochemical characteristics. Thus it is appropriate for investigators and clinicians alike to consider human hypertension as a biophysical sign for which every resource should be mobilized to characterize its nuances in the individual patient. The goal in drug therapy is to select and verify the most effective and specific treatment for that individual.
目次
Foreword. Introduction. I. The consequences of high blood pressure. 1. Cardiovascular risk: the impact of blood pressure and its correction (M.H. Alderman and P.R. Marantz). 2. What clinical trials have taught us (C.G. Isles et al). 3. Is there a hypertensive coronary-prone personality? (E.H. Johnson and S. Julius). 4. Ambulatory blood pressure monitoring and cardiovascular risk (M. Burnier et al). 5. Target-organ damage and planning therapy (H. Ibsen). II. The evaluation of the hypertensive patient. 6. Screening for curable hypertension (O.K. Andersson et al). 7. Renovascular hypertension: update on diagnosis and treatment (T.F. Luscher et al). 8. Hypertension and the adrenal cortex (C.R.W. Edwards). 9. Argument for a minimal evaluation of the hypertensive patient (N.M. Kaplan). 10. Blood pressure monitoring devices (T.G. Pickering). 11. Electrocardiographic and echocardiographic features in hypertension: their assessment, diagnostic and prognostic value (P. Bolli et al). III. Antihypertensive drug classes and practical use. 12. The diuretic dilemma (J.R. Cockcroft and C.T. Dollery). 13. Beta-blockers (G. Hausler et al). 14. Calcium antagonists for antihypertensive care (F.R. Buhler et al). 15. Treatment of hypertension with angiotensin-converting enzyme inhibitors as monotherapy (B. Waeber et al). 16. Direct-acting vasodilating agents (P. van Brummelen and C.J. Doorenbos). 17. a 1 -Adrenoceptor antagonists and sympatholytic drugs in the management of hypertension (R.F. Schafers and J.L. Reid). IV. Treatment strategies: why, when and how to treat? 18. Non-drug therapy: salt, weight, alcohol, exercise and tobacco (J.D. Swales). 19. The problem of salt restriction (F.O. Simpson). 20. Antihypertensive therapy and the lipid risk factor (Y. Goto and H. Tamachi). 21. Rationale for individualized therapies (J.H. Laragh). 22. Socioeconomic influences on treatment (T. Lang et al). 23. Measurement of quality of life in hypertension (A. Fletcher and C.J. Bulpitt). 24. Primary prevention, coronary flow reserve and antihypertensive therapy (F.R. Buhler and J.M. Cruickshank). 25. WHO/ISH guidelines and their implications (T. Strasser and L. Hansson). V. Special treatment situations. 26. Treatment of hypertension in renal disease (A.E.G. Raine and J.G.G. Ledingham). 27. Hypertension in the elderly (A. Amery et al). 28. Decision-making in childhood hypertension (B. Falkner and J. Tannenbaum). 29. Antihypertensive treatment in pregnancy (W.F. Lubbe). 30. Antihypertensive drugs and anesthesia (C. Prys-Roberts). 31. Hypertensive emergencies: mechanisms and treatment (A. Distler and E. Fritschka). Index.
「Nielsen BookData」 より